{"id":1437,"date":"2026-02-25T01:18:13","date_gmt":"2026-02-25T01:18:13","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/25\/latest-trial-results-show-btk-inhibitor-fenebrutinib-effective-in-primary-progressive-ms\/"},"modified":"2026-02-25T01:18:13","modified_gmt":"2026-02-25T01:18:13","slug":"latest-trial-results-show-btk-inhibitor-fenebrutinib-effective-in-primary-progressive-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/25\/latest-trial-results-show-btk-inhibitor-fenebrutinib-effective-in-primary-progressive-ms\/","title":{"rendered":"Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS"},"content":{"rendered":"

\"\"<\/p>\n

The post Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS<\/a> appeared first on MS Australia<\/a>.<\/p>\n

Source: www.msaustralia.org.au<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

The post Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS appeared first on MS Australia. Source: www.msaustralia.org.au<\/p>\n","protected":false},"author":0,"featured_media":1438,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1437","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1437"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1437\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1438"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}